File: b-be-18-bvw1-public-information-nl.pdfTrial reference: A Phase I/IIa study of TG6002 (VV TK-RR-FCU1) administered by intravenous (IV) infusions in combination with oral flucytosine (5-FC) in patients with advanced gastro-intestinal (GI) tumorsDoc type: Information for the public
